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genes from microbiota on retail spinach
Hillary F Berman and Lee W Riley*Abstract
Background: Drug resistance genes and their mobile genetic elements are frequently identified from
environmental saprophytic organisms. It is widely accepted that the use of antibiotics in animal husbandry selects
for drug resistant microorganisms, which are then spread from the farm environment to humans through the
consumption of contaminated food products. We wished to identify novel drug resistance genes from microbial
communities on retail food products. Here, we chose to study the microbial communities on retail spinach because
it is commonly eaten raw and has previously been associated with outbreaks of bacterial infections.
Results: We created metagenomic plasmid libraries from microbiota isolated from retail spinach samples. We
identified five unique plasmids that increased resistance to antimicrobial drugs in the E. coli host. These plasmids
were identified in E. coli that grew on plates that contained ampicillin (pAMP), aztreonam (pAZT), ciprofloxacin
(pCIP), trimethoprim (pTRM), and trimethoprim-sulfamethoxazole (pSXT). We identified open reading frames with
similarity to known classes of drug resistance genes in the DNA inserts of all 5 plasmids. These drug resistance genes
conferred resistance to fluoroquinolones, cephalosporins, and trimethoprim, which are classes of antimicrobial drugs
frequently used to treat human Gram negative bacterial infections. These results show that novel drug resistance
genes are found in microbiota on retail produce items.
Conclusions: Here we show that microbiota of retail spinach contains DNA sequences previously unidentified as
conferring antibiotic resistance. Many of these novel sequences show similarity to genes found in species of
bacteria, which have previously been identified as commensal or saprophytic bacteria found on plants. We showed
that these resistance genes are capable of conferring clinically relevant levels of resistance to antimicrobial agents.
Food saprophytes may serve as an important reservoir for new drug-resistance determinants in human pathogens.
Keywords: Antibiotic resistance, Gram negative bacteria, Metagenomic libraryBackground
The spread of antimicrobial resistance genes has made
previously manageable bacterial infections increasingly
more difficult to treat. In addition, there has been a gradual
decline in the development of new antimicrobial drugs,
especially against Gram negative bacterial pathogens. The
identification of genes in Gram negative bacteria that
confer resistance to cephalosporins, carbapenems, and
fluoroquinolones has created fears that we are returning to
the pre-antibiotic era [1]. These multidrug-resistant infec-
tions often occur in hospitals and are frequently caused by
species belonging to the normal microbiota of the human
host [1,2]. This suggests that the microbiota of the patients* Correspondence: lwriley@berkeley.edu
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distribution, and reproduction in any mediumthemselves is the reservoir for many of the organisms that
cause hospital acquired infections. Furthermore, recent
work has demonstrated that the intestinal microbiota of
humans and food animals are a reservoir of drug resistance
genes [3]. Consequently, a better understanding of how
drug resistance genes enter the human microbiota is im-
perative to better prevent drug resistant infections.
Drug resistance genes and their mobile genetic elements
are frequently identified from environmental saprophytic
organisms. These include samples taken from soil, water,
and wild animals [4-6]. Additionally, these genes have
been identified in environmental samples from ancient
and pristine environments – samples that have never been
exposed to human activity [4,5,7]. Due to the great diver-
sity of antibiotic resistance genes found in environment, it
has been hypothesized that environmental microbes serventral Ltd. This is an open access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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enter human pathogens [4,5]. These drug resistance genes
are spread between bacteria via mobile genetic elements,
such as plasmids, transposons, and integrons [4-6,8]. The
detection of mobile genetic elements and drug resistance
genes in the environment has led to numerous studies
and policies to address the effects of environmental expo-
sure to antimicrobial agents on human pathogens [9,10].
It is widely accepted that the use of antibiotics in animal
husbandry selects for drug resistant microorganisms,
which are then spread from the farm environment to
humans through the consumption of contaminated food
products [11]. Numerous studies of bacterial pathogens in
food products, such as Campylobacter and Salmonella,
have demonstrated that the use of antimicrobial drugs in
agriculture can result in drug resistant infections in
humans [9-13]. However, the majority of studies have
been limited to species of zoonotic pathogens that cause
foodborne disease and these studies are frequently done
as part of national surveillance programs for food safety.
Species of bacteria that are not usually considered food-
borne pathogens, but nonetheless are found in both the
human and food product microbiota, are usually not in-
cluded in studies of drug resistant bacteria in retail food
products. Studies of microbiota of animals demonstrated
that commensal organisms are a reservoir of antimicrobial
drug resistance genes [3]. These studies include the identi-
fication of antimicrobial resistance genes from animal
feces including chickens and cows [3,14-16]. Animal ma-
nure is frequently used as fertilizer in agriculture and may
contribute to the spread of drug resistance genes. The
spread of drug resistance genes by commensal bacteria on
food products is an area that requires further study [11].
Produce items, which are frequently eaten raw, are one
way consumers are exposed to microbiota on retail food
products [17]. Previous work has shown that the normal
microbiota of retail produce items harbors clinically rele-
vant drug resistance genes [18]. However, previous studies
have relied on PCR based methods to identify known drug
resistance genes, which limits the number and types of
drug resistance that could potentially be identified. Other
studies used functional metagenomic libraries to identify
novel antimicrobial resistance genes from environmental
samples in a sequence independent manner [19,20]. We
wanted to apply this sequence independent approach to
investigate the presence of antimicrobial resistance genes
on retail spinach. We chose to study the microbial com-
munities on retail spinach because it is commonly eaten
raw and has previously been associated with outbreaks of
bacterial infections [21].
To do this, we made two metagenomic plasmid libraries
with DNA isolated from the microbiota of retail spinach.
One library was made from a cultured sample of spinach
microbiota while the other was made in a cultureindependent manner. We then screened these libraries for
their ability to confer resistance to antibiotics to an E. coli
host.
Results and discussion
Isolation of antibiotic resistant clones
The first plasmid library, which was constructed from a
cultured sample, contained 160 Mb of inserted DNA. The
second library, which was constructed from an uncultured
sample, contained 140 Mb of inserted DNA. We first
constructed a cultured library because we wished to en-
rich for microbial DNA to increase the chances of cloning
DNA sequences that contained drug-resistance genes. We
constructed a library from an uncultured sample because
we wanted to identify potential drug-resistance genes from
bacterial organisms that cannot be cultivated in artificial
medium. From the cultivated library, we isolated four
different antimicrobial resistance-conferring clones. From
the uncultivated library, we isolated one additional anti-
microbial resistance-conferring clone.
The mean size of the plasmid DNA inserts in both libra-
ries was two Kb. We identified five unique plasmids that
conferred increased drug resistance (minimum inhibitory
concentration or MIC) to the host E. coli. Each plasmid was
named after the antimicrobial agent to which it conferred
resistance (Table 1). These plasmids were identified in E. coli
that grew on plates that contained ampicillin (pAMP), aztre-
onam (pAZT), ciprofloxacin (pCIP), trimethoprim (pTRM),
and trimethoprim-sulfamethoxazole (pSXT). The plasmids
pAMP, pAZT, pCIP, and pTRM were isolated from the li-
brary made from a cultured sample. The plasmid pSXT was
isolated from the library made from an uncultured sample.
pAMP increased the MIC of ampicillin 4 fold (4 ug/ml
to 16 ug/ml). pAZT increased the MIC of the host strain
96 fold to aztreonam (.125 ug/ml to 12 ug/ml), 10 fold to
cefepime (.096 ug/ml to 1 ug/ml), and 6 fold to piperacil-
lin (2 ug/ml to 12 ug/ml). Additionally, pAZT encoded an
ESBL phenotype as measured by the ceftazidime, ceftazi-
dime/clavulanic acid ESBL Etest, (TZ 16 ug/ml and TZL
1 ug/ml). pCIP caused a 62-fold increase in resistance to
ciprofloxacin (<.002 ug/ml to .125 ug/ml) as well as a 31-
fold increase in resistance to levofloxacin (.012 ug/ml to
.38 ug/ml). The MIC of trimethoprim for E. coli carrying
pTRM increased >258 fold (.124 ug/ml to >32 ug/ml) and
7 fold to trimethoprim-sulfamethoxazole (.064 ug/ml to
.5 ug/ml). pSXT caused a 15-fold increase in resistance to
trimethoprim-sulfamethoxazole (.064 ug/ml to 1 ug/ml)
as well as an >256-fold increase in resistance to trimetho-
prim alone (.125 ug/ml to >32 ug/ml).
Identification of antibiotic resistance genes and
phylogenetic analysis
We identified open reading frames with similarity to
known classes of drug resistance genes in DNA inserts of
Table 1 Minimum inhibitory concentrations (MIC) for E. coli containing the indicated plasmids
Drug resistant plasmid Name Antimicrobial drug Drug resistance plasmid MIC
(ug/ml)
Empty vector MIC
(ug/ml)
Fold increase
pAMP ampicillin 16 4 4
pAMP piperacillin 3 2 1.5
pAMP cefotaxime <.25 <.25 0
pAMP ceftazidime <.5 <.5 0
pAMP cefepime 0.064 0.094 0.68
pAMP Aztreonam 0.19 0.125 1.5
pAMP Imipenem 0.25 0.25 0
pCIP ciprofloxacin 0.125 <0.002 >62.5
pCIP levofloxacin 0.38 0.012 31.7
pCIP Ampicillin 6 4 1.5
pCIP piperacillin 3 2 1.5
pCIP ceftazidime <.5 <.5 0
pCIP cefotaxime <.25 <.25 0
pCIP cefepime 0.125 0.094 1.3
pCIP Imipenem 0.25 0.25 0
pTMP trimethoprim >32 0.124 >258
pTMP trimethoprim- sulfamethoxazole 0.5 0.064 7.8
pAZT Aztreonam 12 0.125 96
pAZT cefepime 1 0.094 10.6
pAZT ceftazidime 16 0.5 32
pAZT piperacillin 12 2 6
pSXT trimethoprim-sulfamethoxazole 1 0.064 15.6
pSXT trimethoprim >32 0.125 >256
pPRP:1B ciprofloxacin 0.125 0.016 7.8
pPRP:1B levofloxacin 0.25 0.047 5.3
MICs in the presence of the plasmid with the metagenomic DNA insert compared to the empty vector (pSMART or 1B) are shown. In accordance with
manufactures recommendations, less than a 4-fold increase was considered to be within the margin of error.
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Table 2.
In pAZT we identified a sequence with 94% identity at
the nucleotide level to a gene that encodes penicillin-
binding protein 1A identified in Bacillus subtilis subsp.
Spizizenii [GenBank, gb|CP002905.1|]. The expression of
altered penicillin binding proteins are known to confer
resistance to beta-lactam and cephalosporin antibiotics in
various clinically important pathogens [22]. However, the
ability of this sequence to confer clinically relevant levels
of cephalosporin resistance or an ESBL phenotype has not
been previously reported.
In pAMP we identified a beta-lactamase gene with 71%
identity to the ERP-1 gene that encodes a class A extended
spectrum beta-lactamase found in Erwinia persicin
[GenBank, gb|AY077733.1|] [23]. When transformed into
an E. coli host, ERP-1 was reported to increase resistance
to penicillins and cephalosporins, including piperacillin,
cefotaxime, and ceftazidime [23]. Surprisingly, we foundthat pAMP did not increase the MIC of the host E. coli to
piperacillin, ceftazidime, or cefotaxime. Also, pAMP did
not increase the MIC of this host strain to any tested
cephalosporin, monobactam, or carbapenem (cefepime,
aztreonam, or imipenem). However, this isolate tested
positive for the presence of a beta-lactamase by the nitro-
cefin assay. These results suggest that the novel sequence
we identified in pAMP is distinct from ERP-1 in terms of
the spectrum of drug-resistance phenotype it encodes.
However, it is also possible that these observations are
artifacts due to poor expression of the gene in a hete-
rologous host.
Surprisingly, when the pCIP DNA sequence was submit-
ted to BlastN, only two other sequences in the NCBI
non-redundant nucleotide database were identified. The
sequences were part of whole genome sequences of Exiguo-
bacterium antarcticum and Exiguobacterium sibiricum.
These species were identified in a frozen Antarctic lake and
a core sample of the Siberian tundra [24,25]. When
Figure 1 Diagram of open reading frames and DNA insert size. Open reading frame labels correspond to those in Table 2. Broken arrows
correspond to truncated open reading frames. Open reading frames marked with a * show similarity to known drug resistance genes. Figure not
drawn to scale.
Berman and Riley BMC Microbiology 2013, 13:272 Page 4 of 7
http://www.biomedcentral.com/1471-2180/13/272submitted to BlastP, a fluoroquinolone resistance protein
from Oceanobacillus sp. Ndiop was identified. This quin-
olone resistance protein was a predicted pentapeptide re-
peat protein (PRP) [GenBank, ref|ZP_10910075.1|]. One
known class of plasmid-mediated quinolone resistance con-
ferring sequences is called QNR[26]. QNRs are pentapep-
tide repeat proteins and have been associated with
extended spectrum beta-lactamases [26]. In addition to the
PRP, the pCIP DNA insert contained a second open reading
frame that showed similarity to a beta-lactamase domain
containing protein (Figure 1). However, pCIP did not in-
crease the MIC of the host E. coli to any of the tested beta-
lactam antibiotics (ampicillin and piperacillin), cephalo-
sporin antibiotics (ceftazidime, cefotaxime, cefepime), or
carbapenem antibiotics (imipenem). Additionally, pCIP did
not test positive for beta-lactamase production by the nitro-
cefin assay. This indicated that the predicted beta-
lactamase is either not expressed or does not function as a
beta-lactamase.
We subcloned the PRP sequence in pCIP (pPRP:1B) in
order to confirm that the predicted PRP was able to con-
fer resistance to ciprofloxacin. As compared to the
empty vector, the pPRP:1B increased the MIC of cipro-
floxacin of the host E. coli 7 fold (.016 to .125) and the
MIC of levofloxacin 5 fold (.047 to .25 ug/ml). The MIC
conferred by pPRP:1B to the host E. coli is consistentwith previously reported MICs from other QNR se-
quences found in human pathogens [26].
We found that the pTRM DNA insert has 84% identity
to a region of the Erwinia pyrifoliae DSM 12163 complete
genome [GenBank, emb|FN392235.1]. This region con-
tains the folA gene, which encodes a dihydrofolate reduc-
tase (DHFR). DHFR is the target of trimethoprim [27].
The expression of a DHFR that is not susceptible to
trimethoprim is a well-known mechanism of resistance
[27]. However, the acquisition of the folA gene from
Erwinia pyrifoliae DSM 12163 has not previously been
shown to confer resistance to trimethoprim.
Similarly, the DNA insert from pSXT has 88% identity
to a region of the Pseudomonas fluorescens SBW25
complete genome [28]. This region also encodes a pre-
dicted dihydrofolate reductase. This sequence from
Pseudomonas fluorescens SBW25 has not previously been
shown to confer resistance to trimethoprim or trimetho-
prim sulfamethoxazole.
Conclusions
Here we show that microbiota of retail spinach contains
previously unidentified antibiotic resistance-conferring
genes and that functional metagenomic libraries can be
used to screen retail food products for drug resistance
genes in a sequence independent manner. Furthermore,
Table 2 Open reading frames identified in each of the 5 drug resistance-conferring plasmids
Plasmid ORF Predicted protein
length
Most similar protein, Genbank accession number Organism E-
value
AA
identity
pAMP 1 95 Putative Iron-Chelator Esterase EL859857.1 Bacillus Subtilis subsp
inaquoaorm
7 e-55 99%
pAMP 2 230 Putative Sodium Dependent Transporter
ZP_2118733.1
Bacillus Subtilis subsp
inaquoaorm
2 e-156 98%
pAMP 3 378 Sugar Efflux Transporter YP_001907636.1 Erwinia tasmaniensis Et1/99 0.00 89%
pAMP 4 293 Extended Sepctrum Beta-lactamase ERP-1
AAAL86999.1
Erwinina perscina 2 e-152 81%
pAMP 5 303 Peptidyl-Dipeptidase YP_001907684.1 Erwinia tasmaniensis Et1/99 8 e-154 86%
pCIP 1 216 Pentapeptide-Repeat Containing Protein
YP_006790167.1
Exiguobacterium antarticum 9 e-139 86%
pCIP 2 212 Beta-lactamase Domain Containing Protein
YP_006790168
Exiguobacterium antarticum 1 e-144 96%
pTMP 1 128 Diemethyladenoanine Transferase YP_001906668.1 Erwinia tasmanienaia 1 e-82 94%
pTMP 2 125 Protein ApaG (Protein Cor D) YP_003532282.1 Erwinia amylovora CFBP1430 2 e- 78 88%
pTMP 3 234 Bis (5′-nucleoayl) Tetraphosphotase YP_003740080.1 Erwinia billingiae 4 e-
151
88%
pTMP 4 171 Protein FolA YP_ 005801502.1 Erwinia pyrifoliae DSM 12163 3 e-115 93%
pTMP 5 91 Rhtb Family Transporter YP_003532285.1 Erwinina amylovora CFB1430 9 e-54 97%
pAZT 1 151 Hypothetical Protein BsI_26310 ZP_21117554.1 Bacillus Subtilis subsp
inaquoaorm
2 e-108 99%
pAZT 2 651 Penicillin Binding Protein 2c ZP_21117553.1 Bacillus Subtilis 0.00 99%
pSXT 1 170 Dihydrofolate Reductase YP_002875292.1 Pseudomonas fluorsencens 4 e-112 94%
pSXT 2 139 Sodium: Dicarboxylate Symporter ZP_0778142.1 Pseudomonas fluorsencens 3 e-93 96%
OrFinder, BlastX and BlastP were used to identify each open reading frame.
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into a plasmid library and the requirement that the drug
resistance gene be expressed in a heterologous host, it is
likely we only identified a fraction of drug resistance
conferring genes present in our spinach samples.
Although none was identical in DNA sequence, many
of these novel sequences show sequence similarity to
genes found in species of bacteria that have previously
been identified as commensal or saprophytic bacteria
found on plants [23,28]. This suggests the sequences we
identified are not the result of contamination from ani-
mals or humans. We showed that these resistance genes
are capable of conferring clinically relevant levels of re-
sistance to commonly used classes of antimicrobial
agents, including cephalosporins and fluoroquinolones.
The novel antimicrobial resistance genes we identified
include beta-lactamases, a pentapeptide repeat protein, a
penicillin binding protein, and putative dihydrofolate re-
ductase genes. These types of resistance mechanisms are
some of the most common and clinically problematic
mechanisms of drug resistance found in pathogens [27].
We do not know at this time if these genes will become
clinically important, and one limitation of this study is
that we did not analyze these genes for their potential
for horizontal transfer to human pathogens. Recentfunctional genomics analysis of environmental soil sam-
ples has not only identified drug-resistance genes with
identical nucleotide sequences from human pathogens,
but also mobile gene sequences providing evidence for
possible horizontal gene transfers [29]. Further studies
using sequence independent methods to identify anti-
microbial resistance genes from retail food products
should be done to better understand the role of sapro-
phytes as a reservoir for new drug-resistance genes.
Methods
Metagenome plasmid library construction and screening
Two metagenomic plasmid libraries of spinach micro-
biota were constructed. One was based on DNA ex-
tracted from cultured bacteria and the other was based
on DNA extracted from uncultured spinach wash. The
metagenomic DNA used to create the first library was
obtained by washing twenty five grams of bagged “baby
spinach” in PBS. A description of the spinach used to
create the library has been previously published [18].
Briefly, the spinach was purchased from a supermarket
located in Berkeley, California in 2007. They included
organic as well as non-organic spinach. One milliliter of
the PBS wash was then used to inoculate 50 ml TSB.
This culture was grown at 37°C with shaking overnight.
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nutes. DNA was extracted from the resulting pellet by
the phenol chloroform method.
The metagenomic DNA used to create the second library
was obtained by washing six bags of “baby spinach” in two
liters of PBS. Six different brands of spinach were pur-
chased from three retailers located in Berkeley, California
in 2011. The spinach was incubated in PBS at room
temperature for two hours. The resulting wash was then
filtered through sterilized cheesecloth and a sterilized coffee
filter to remove spinach debris. The filtered wash was then
centrifuged at 10,000 x g for 20 minutes. DNA was
extracted directly from the resulting pellet with the Gnome
DNA isolation Kit, MP Biomedical.
Two plasmid libraries with metagenomic DNA inserts
were constructed in pSMART-LC kan vector in the E.
coli host, E. Cloni (Lucigen corp., Middleton WI). The
pSMART vector confers resistance to kanamycin and
has transcriptional terminators flanking the cloning sites.
Consequently, transcription of the cloned sequences
requires a native promoter.
E. coli clones containing the two plasmid libraries were
then screened for resistance to antimicrobial agents on
Mueller Hinton agar plates containing one of the following
16 antimicrobial agents: ampicillin, carbenicillin, ticarcillin,
amoxicillin/clavulanic acid, ticarcillin/clavulanic acid, cefo-
taxime, ceftazidime, aztreonam, meropenem, gentamicin,
nalidixic acid, ciprofloxacin, trimethoprim, trimethoprim-
sulfamethoxazole, chloramphenicol, or tetracycline. The
phenotype of resistance to antimicrobial agents was con-
firmed by retransforming the recombinant plasmid into E.
Cloni. Growth on Muller Hinton agar containing kanamy-
cin was used as a positive control for transformation. The
acquisition of drug resistance from the transformation of
the plasmid was demonstrated by growth on Mueller
Hinton agar containing the corresponding antimicrobial
agent. We used the empty vector, pSMART, in the E. coli
host as a negative control for antibiotic stability.Antimicrobial susceptibility testing
The MIC of each E. coli clone was determined by Etest
(Biomerieux, France) according to manufactures recom-
mendations. All Etests were repeated in at least two inde-
pendent experiments. ATCC 29522, ATCC 700603, and
ATCC 35218 were used for control as recommended by
the manufacturer. In accordance with manufactures
recommendations, less than a fourfold difference in MIC
was considered to be with in the expected margin of error
for this test.Nitrocefin test
A colony was spotted onto a sterile Petri dish and then
covered with nitrocefin, as previously described [30]. E.Cloni containing the empty vector (pSMART) was used
as a negative control.
Sequencing and data analysis: The sequence of the DNA
insert in the resistance conferring plasmid was determined
by primer walking at the University of California, Berkeley
sequencing facility. The sequences were assembled with
Geneious Version 5.6, (Biomatters, New Zealand). The
insert sequences were then submitted to ORFinder and the
BLAST suit of programs at NCBI [31]. The nucleotide
sequences of the insert from each plasmid have been de-
posited in Genbank with the following accession numbers:
pAMP: KF791056, pAZT: KF791057, pCIP: KF791058,
pTRM: KF791059, pSXT: KF791060.
Cloning
Standard protocols for ligation independent cloning in
to vector 1B, QB3 Macrolab, University of California,
Berkeley were used.
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